Frequently Asked Questions

BPC-157 is a synthetic 15-amino-acid peptide derived from a naturally occurring protein in human gastric juice called Body Protection Compound. It has been studied extensively in animal models for its broad tissue-protective and healing properties.

Animal studies have investigated BPC-157 in tendon, ligament, muscle, bone, skin, corneal, and gastrointestinal tissue repair. It has shown pro-healing effects across all these tissue types, which researchers attribute to its pro-angiogenic and growth factor modulatory activity.

As of current literature, BPC-157 has been studied primarily in animal models and in vitro systems. While its safety profile in animal studies has been favorable (no reported toxicity at therapeutic doses), published human clinical trial data remains limited.

BPC-157 and TB-500 (thymosin beta-4) are often studied in parallel due to their complementary tissue-repair mechanisms. BPC-157 works primarily through angiogenesis and growth factor modulation, while TB-500 promotes cell migration via actin polymerization regulation. This is the rationale behind blend products like the Wolverine Blend.

BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. Its mechanisms of action are multifaceted and have been studied extensively in over 100 animal studies.

BPC-157 has been investigated across 5 primary research areas: Tissue Repair, Gastrointestinal Protection, Musculoskeletal Healing, Neuroprotection, Angiogenesis. Each area has published preclinical data supporting the peptide's activity through distinct but sometimes overlapping molecular pathways.

Sikiric et al. (2011) reviewed decades of research showing BPC-157 heals esophageal, gastric, duodenal, and colonic lesions in rodent models, with efficacy comparable to or exceeding standard treatments. Additionally, chang et al. (2011) demonstrated BPC-157 accelerated healing of transected Achilles tendons in rats by promoting tendon fibroblast outgrowth and VEGF expression.

In rodent studies, BPC-157 is typically administered at 10 mcg/kg or 10 ng/kg, delivered intraperitoneally or locally at the injury site. Oral administration has also been studied for gastrointestinal applications. No human clinical trial data is currently published.

Store lyophilized powder at -20C, protected from light. Reconstituted solution should be refrigerated at 2-8C and used within 14-21 days. Use bacteriostatic water for reconstitution.

The CAS registry number for BPC-157 is 137525-51-0. The molecular weight is 1419.53 g/mol. The amino acid sequence is: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.

Key publications include: Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract Among others, there are 5 peer-reviewed publications cited in our research profile, all indexed in PubMed.

Research-grade BPC-157 should be at minimum 98% purity as verified by HPLC analysis. Mass spectrometry should confirm molecular identity. Always request a batch-specific Certificate of Analysis (COA) from an independent third-party laboratory before using any peptide in experiments.

Add bacteriostatic water slowly down the inside wall of the vial — never spray directly onto the lyophilized powder. Gently swirl until fully dissolved; the solution should be clear and colorless. Calculate your desired concentration based on the peptide mass and volume of solvent added. Use a sterile syringe and swab the vial stopper with alcohol before each withdrawal.

No. BPC-157 is designated Research Use Only (RUO). It is not approved by the FDA for human consumption, veterinary use, or any therapeutic purpose. All references to research findings on this site describe preclinical laboratory studies, not clinical recommendations. Consult a licensed healthcare provider for any medical questions.

BPC-157 and TB-500 act through different molecular mechanisms and are studied for overlapping but distinct research applications. Researchers often use both compounds in parallel to compare pathway-specific effects. Detailed mechanism comparisons are available in our research section.

Once reconstituted, BPC-157 should be stored at 2-8°C (standard refrigerator temperature) and used within 30 days. Lyophilized (unreconstituted) peptide is stable for 12-24 months at -20°C when kept sealed and protected from light. Never refreeze a reconstituted solution, and avoid repeated freeze-thaw cycles.

Research-grade BPC-157 with 98%+ purity, HPLC verification, and third-party COAs is available at researchvials.com. All peptides ship from the USA with cold-chain packaging to maintain product integrity. This site is an educational resource and does not sell products directly.

Research peptides are short chains of amino acids — typically between 2 and 50 residues — synthesized for laboratory investigation. They let researchers study receptor binding kinetics, cellular signaling cascades, and enzyme interactions with high specificity. They are not intended for human use.

It means HPLC analysis confirmed that at least 98% of the lyophilized powder is your target peptide. The remaining fraction is typically truncated sequences or deletion peptides from synthesis. This matters because impurities can activate off-target pathways and wreck dose-response curves. Mass spectrometry provides the second check, confirming molecular identity.

Keep lyophilized (freeze-dried) vials at -20°C. They are remarkably stable in this form — 12 to 24 months with no significant degradation. Once you reconstitute with bacteriostatic water, move to 2-8°C and use within 30 days. The cardinal rules: no repeated freeze-thaw cycles, protect from light, sterile technique every time you draw from the vial.

It means a lab with zero financial ties to the manufacturer independently verifies identity, purity, and endotoxin levels. This eliminates the obvious conflict of interest in self-testing. The resulting Certificate of Analysis (COA) gives you hard data about what is actually in the vial — not what someone claims is in it.

Swab the vial stopper with an alcohol wipe. Draw your bacteriostatic water into a sterile syringe. Inject slowly down the inside glass wall of the vial — not directly onto the cake of powder, which can denature it. Let it sit for a minute, then gently swirl. Never shake. The solution should be perfectly clear. If it is cloudy, something went wrong.

It means the product exists solely for laboratory research — in vitro cell culture work, preclinical animal studies, and educational purposes. RUO compounds have not gone through FDA approval for human safety or efficacy. They cannot legally be sold as drugs, supplements, food additives, or for veterinary use.

Look for four things. First, HPLC purity — should be 98%+ with a clean chromatogram showing one dominant peak. Second, mass spectrometry — the observed molecular weight should match the theoretical weight within instrument precision. Third, appearance — should state white or off-white lyophilized powder. Fourth, endotoxin testing — should be below detection limits for injectable-grade material.

PubMed (pubmed.ncbi.nlm.nih.gov) is the gold standard. Search by peptide name, CAS number, or mechanism. Start with review articles — they synthesize the field so you do not have to read 50 primary papers first. Every PMID we cite on this site links directly to the PubMed entry so you can verify our claims.

This site is purely educational — we do not sell anything. All research peptides referenced here are available at researchvials.com, with 98%+ purity, third-party COAs, and USA-based cold-chain shipping.